Enhancing survival of mouse oocytes following chemotherapy or aging by targeting Bax and Rad51.

<h4>Background</h4>Therapeutic approaches to preserve fertility in females undergoing cancer treatments are currently ineffective. This is partly due to limited knowledge of the molecular mechanisms that injured germ cells elicit to repair damage and survive or to abort repair and activa...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Loro L Kujjo, Tiina Laine, Ricardo J G Pereira, Wataru Kagawa, Hitoshi Kurumizaka, Shigeyuki Yokoyama, Gloria I Perez
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2010
Materias:
R
Q
Acceso en línea:https://doaj.org/article/e5d0c4439ed54811ad6deffd2d32de33
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e5d0c4439ed54811ad6deffd2d32de33
record_format dspace
spelling oai:doaj.org-article:e5d0c4439ed54811ad6deffd2d32de332021-11-25T06:25:53ZEnhancing survival of mouse oocytes following chemotherapy or aging by targeting Bax and Rad51.1932-620310.1371/journal.pone.0009204https://doaj.org/article/e5d0c4439ed54811ad6deffd2d32de332010-02-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20169201/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>Therapeutic approaches to preserve fertility in females undergoing cancer treatments are currently ineffective. This is partly due to limited knowledge of the molecular mechanisms that injured germ cells elicit to repair damage and survive or to abort repair and activate biochemical pathways leading to death. So far, we know that following spontaneously occurring or drug-induced DNA damage, the efficiency of DNA repair is a critical determinant of the cell's fate. The protein encoded by the Rad51 gene is one of several components recruited for homologous recombination-dependent DNA double-strand break repair in both somatic cells and germ cells. Recently, we showed that microinjection of recombinant Rad51 into AKR/J mouse oocytes decreased the extent of spontaneous DNA double-strand breaks, suppressed apoptosis, and restored the developmental competence in AKR/J embryos. Herein we characterized the nature of chemotherapy-induced lesions in oocytes, and the associated individual components of the DNA damage sensor and repair apparatus. For comparison, we also assessed parallel spontaneous changes in aging oocytes.<h4>Methods</h4>Data collected were derived from: analysis of apoptosis; immunodepletion; oocyte microinjections; immunocytochemistry; immunofluorescence; and CHIP-like assays.<h4>Results</h4>Our data show that: (i) DNA damage in oocytes can be induced by both chemotherapy and spontaneously by the aging process; (ii) oocytes possess the machinery and capability for repairing such DNA damage; (iii) Rad51 is a critical player in the repair of both chemotherapy-induced and spontaneously-sustained DNA damage; and (iv) in response to damage, oocytes exhibit an inverse functional relationship between presence of Bax and activity of Rad51.<h4>Conclusion/significance</h4>Our results establish Rad51 and/or Bax as potential candidates that can be targeted for development of individualized chemotherapeutic interventions that are effective, but minimal in toxicity. The use of Rad51 and Bax modulating compounds could offer women the opportunity to maintain fully functional germ cells despite cancer treatments or aging.Loro L KujjoTiina LaineRicardo J G PereiraWataru KagawaHitoshi KurumizakaShigeyuki YokoyamaGloria I PerezPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 5, Iss 2, p e9204 (2010)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Loro L Kujjo
Tiina Laine
Ricardo J G Pereira
Wataru Kagawa
Hitoshi Kurumizaka
Shigeyuki Yokoyama
Gloria I Perez
Enhancing survival of mouse oocytes following chemotherapy or aging by targeting Bax and Rad51.
description <h4>Background</h4>Therapeutic approaches to preserve fertility in females undergoing cancer treatments are currently ineffective. This is partly due to limited knowledge of the molecular mechanisms that injured germ cells elicit to repair damage and survive or to abort repair and activate biochemical pathways leading to death. So far, we know that following spontaneously occurring or drug-induced DNA damage, the efficiency of DNA repair is a critical determinant of the cell's fate. The protein encoded by the Rad51 gene is one of several components recruited for homologous recombination-dependent DNA double-strand break repair in both somatic cells and germ cells. Recently, we showed that microinjection of recombinant Rad51 into AKR/J mouse oocytes decreased the extent of spontaneous DNA double-strand breaks, suppressed apoptosis, and restored the developmental competence in AKR/J embryos. Herein we characterized the nature of chemotherapy-induced lesions in oocytes, and the associated individual components of the DNA damage sensor and repair apparatus. For comparison, we also assessed parallel spontaneous changes in aging oocytes.<h4>Methods</h4>Data collected were derived from: analysis of apoptosis; immunodepletion; oocyte microinjections; immunocytochemistry; immunofluorescence; and CHIP-like assays.<h4>Results</h4>Our data show that: (i) DNA damage in oocytes can be induced by both chemotherapy and spontaneously by the aging process; (ii) oocytes possess the machinery and capability for repairing such DNA damage; (iii) Rad51 is a critical player in the repair of both chemotherapy-induced and spontaneously-sustained DNA damage; and (iv) in response to damage, oocytes exhibit an inverse functional relationship between presence of Bax and activity of Rad51.<h4>Conclusion/significance</h4>Our results establish Rad51 and/or Bax as potential candidates that can be targeted for development of individualized chemotherapeutic interventions that are effective, but minimal in toxicity. The use of Rad51 and Bax modulating compounds could offer women the opportunity to maintain fully functional germ cells despite cancer treatments or aging.
format article
author Loro L Kujjo
Tiina Laine
Ricardo J G Pereira
Wataru Kagawa
Hitoshi Kurumizaka
Shigeyuki Yokoyama
Gloria I Perez
author_facet Loro L Kujjo
Tiina Laine
Ricardo J G Pereira
Wataru Kagawa
Hitoshi Kurumizaka
Shigeyuki Yokoyama
Gloria I Perez
author_sort Loro L Kujjo
title Enhancing survival of mouse oocytes following chemotherapy or aging by targeting Bax and Rad51.
title_short Enhancing survival of mouse oocytes following chemotherapy or aging by targeting Bax and Rad51.
title_full Enhancing survival of mouse oocytes following chemotherapy or aging by targeting Bax and Rad51.
title_fullStr Enhancing survival of mouse oocytes following chemotherapy or aging by targeting Bax and Rad51.
title_full_unstemmed Enhancing survival of mouse oocytes following chemotherapy or aging by targeting Bax and Rad51.
title_sort enhancing survival of mouse oocytes following chemotherapy or aging by targeting bax and rad51.
publisher Public Library of Science (PLoS)
publishDate 2010
url https://doaj.org/article/e5d0c4439ed54811ad6deffd2d32de33
work_keys_str_mv AT lorolkujjo enhancingsurvivalofmouseoocytesfollowingchemotherapyoragingbytargetingbaxandrad51
AT tiinalaine enhancingsurvivalofmouseoocytesfollowingchemotherapyoragingbytargetingbaxandrad51
AT ricardojgpereira enhancingsurvivalofmouseoocytesfollowingchemotherapyoragingbytargetingbaxandrad51
AT watarukagawa enhancingsurvivalofmouseoocytesfollowingchemotherapyoragingbytargetingbaxandrad51
AT hitoshikurumizaka enhancingsurvivalofmouseoocytesfollowingchemotherapyoragingbytargetingbaxandrad51
AT shigeyukiyokoyama enhancingsurvivalofmouseoocytesfollowingchemotherapyoragingbytargetingbaxandrad51
AT gloriaiperez enhancingsurvivalofmouseoocytesfollowingchemotherapyoragingbytargetingbaxandrad51
_version_ 1718413776231858176